We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Blood Gas Analyzer Enhances Diagnostic Testing

By LabMedica International staff writers
Posted on 01 Nov 2011
The latest cartridge-based analyzer for critical care testing has been introduced offering new features designed for ease-of-use at the point of care (POC). More...


The blood gas analyzer will aid clinicians who are increasingly relying on critical-care tests, such as blood gases, to deliver fast, accurate results to help guide treatment decisions.

The RAPIDPoint 500 analyzer offers a comprehensive menu of critical-care tests for pH and blood gases, electrolytes, glucose and lactate1 and full carbon monoxide (CO)-oximetry, including neonatal total bilirubin and total hemoglobin, all from a single, whole-blood sample. The results are obtained in approximately 60 seconds. Additionally, the measurement cartridges last up to 28 days and contain a full complement of tests, which reduces downtime.

Equipped with fully automated calibration and Quality Control (QC), the RAPIDPoint 500 system (Siemens Healthcare Diagnostics; Erlangen, Germany) is also designed to help POC professionals satisfy organizational and regulatory compliance requirements. The self-contained Automatic Quality Control (AQC) cartridges operate without manual intervention, helping reduce POC staff’s administrative tasks. An integrated bar code reader conveniently located on the front of the system offers a wide scanning area to accommodate patient and operator identification to ensure overall data entry integrity.

Hilda Crockett, the business manager for Point of Care at Siemens Healthcare Diagnostics, said, “The RAPIDPoint 500 system is designed to satisfy the unique demands of testing at the point of care. In addition to being easy-to-use, the analyzer leverages proven and reliable cartridge-based technologies to deliver fast, accurate, laboratory-quality results, helping clinicians feel confident in making critical decisions that impact patient lives.”

Related Links:

Siemens Healthcare Diagnostics




Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
Automatic CLIA Analyzer
Shine i6000
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A simple oral swab detected blood-matched inflammatory signals in children with primary ciliary dyskinesia, offering a needle-free way to monitor inflammation during routine care (Image credit: Shutterstock)

Simple Oral Swab Monitors Persistent Inflammation in Primary Ciliary Dyskinesia

Primary ciliary dyskinesia is a rare lung disease that affects about one in 7,500 to 10,000 live births worldwide. Symptoms can begin in the newborn period and progress to recurrent respiratory infections... Read more

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.